Published in J Biol Chem on January 12, 2010
Rationalization and design of the complementarity determining region sequences in an antibody-antigen recognition interface. PLoS One (2012) 1.06
Probing the stability-limiting regions of an antibody single-chain variable fragment: a molecular dynamics simulation study. Protein Eng Des Sel (2011) 0.88
Antibody phage display libraries: contributions to oncology. Int J Mol Sci (2012) 0.85
Identification of two aberrant transcripts derived from a hybridoma with amplification of functional immunoglobulin variable genes. Cell Mol Immunol (2010) 0.78
Expression, production, and renaturation of a functional single-chain variable antibody fragment (scFv) against human ICAM-1. Braz J Med Biol Res (2014) 0.75
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc (2007) 19.50
Phage antibodies: filamentous phage displaying antibody variable domains. Nature (1990) 8.67
Engineered antibody fragments and the rise of single domains. Nat Biotechnol (2005) 6.96
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A (1988) 6.14
DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res (2002) 5.75
Single-chain antigen-binding proteins. Science (1988) 5.29
Potent antibody therapeutics by design. Nat Rev Immunol (2006) 4.87
Selecting and screening recombinant antibody libraries. Nat Biotechnol (2005) 4.51
Protein translocation across the bacterial cytoplasmic membrane. Annu Rev Biochem (2008) 4.07
Structure of a complex of the ATPase SecA and the protein-translocation channel. Nature (2008) 3.73
Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science (1988) 3.38
Signal sequences: more than just greasy peptides. Trends Cell Biol (1998) 3.18
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res (1992) 2.83
The surprising complexity of signal sequences. Trends Biochem Sci (2006) 2.74
Stability engineering of antibody single-chain Fv fragments. J Mol Biol (2001) 2.58
Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol (1992) 2.50
Conformational transition of Sec machinery inferred from bacterial SecYE structures. Nature (2008) 2.48
Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display. Nat Biotechnol (2006) 2.18
By-passing immunization: building high affinity human antibodies by chain shuffling. Biotechnology (N Y) (1992) 2.05
Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. J Mol Biol (2005) 1.90
Antibodies from phage antibody libraries. J Immunol Methods (2004) 1.75
Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab. J Biol Chem (2005) 1.69
Signal sequences control gating of the protein translocation channel in a substrate-specific manner. Dev Cell (2002) 1.62
Single-chain Fvs. FASEB J (1995) 1.60
SRP-mediated protein targeting: structure and function revisited. Biochim Biophys Acta (2004) 1.57
Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments. Nat Biotechnol (1996) 1.49
A surface expression vector for antibody screening. Gene (1991) 1.36
Single chain Fab (scFab) fragment. BMC Biotechnol (2007) 1.12
Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering. Biochemistry (1999) 1.11
Latest technologies for the enhancement of antibody affinity. Adv Drug Deliv Rev (2006) 1.11
Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation. Protein Eng (1995) 1.10
SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli. N Biotechnol (2008) 0.98
Submitting antibodies to binding arbitration. Nat Chem Biol (2008) 0.96
Improving the display of proteins on filamentous phage. Res Microbiol (2001) 0.92
The filamentous bacteriophage assembly proteins require the bacterial SecA protein for correct localization to the membrane. J Bacteriol (1993) 0.91
Protease substrate site predictors derived from machine learning on multilevel substrate phage display data. Bioinformatics (2008) 0.90
Phage display of disulfide-stabilized Fv fragments. J Immunol Methods (1995) 0.87
Thermal stabilization of a single-chain Fv antibody fragment by introduction of a disulphide bond. FEBS Lett (1995) 0.85
Assessing computational amino acid beta-turn propensities with a phage-displayed combinatorial library and directed evolution. Structure (2006) 0.85
Factor Xa active site substrate specificity with substrate phage display and computational molecular modeling. J Biol Chem (2008) 0.84
A form of anti-Tac(Fv) which is both single-chain and disulfide stabilized: comparison with its single-chain and disulfide-stabilized homologs. Protein Eng (1997) 0.83
Use of synthetic signal sequences to explore the protein export machinery. Biopolymers (2008) 0.82
Synthetic human antibodies and a strategy for protein engineering. FEBS Lett (1998) 0.82
Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders. Structure (2009) 0.77
Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation. J Biol Chem (2001) 1.78
The Na+ channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain. J Gen Physiol (2004) 1.77
Population-based study of SR-BI genetic variation and lipid profile. Atherosclerosis (2004) 1.09
Modeling protein loops with knowledge-based prediction of sequence-structure alignment. Bioinformatics (2007) 1.09
Rationalization and design of the complementarity determining region sequences in an antibody-antigen recognition interface. PLoS One (2012) 1.06
Photoencapsulation of bone morphogenetic protein-2 and periosteal progenitor cells improve tendon graft healing in a bone tunnel. Am J Sports Med (2008) 1.06
Protein backbone angle prediction with machine learning approaches. Bioinformatics (2004) 1.04
E339...R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors. Proc Natl Acad Sci U S A (2011) 1.04
A glutathione S-transferase regulated by light and hormones participates in the modulation of Arabidopsis seedling development. Plant Physiol (2010) 1.03
Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors. ACS Chem Biol (2010) 0.98
Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. J Am Chem Soc (2007) 0.97
Protease substrate site predictors derived from machine learning on multilevel substrate phage display data. Bioinformatics (2008) 0.90
Rotator cuff repair with periosteum for enhancing tendon-bone healing: a biomechanical and histological study in rabbits. Knee Surg Sports Traumatol Arthrosc (2009) 0.89
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses. Bioorg Med Chem (2010) 0.89
A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies. Eur J Med Chem (2010) 0.89
Amino acid substitutions of MagA in Klebsiella pneumoniae affect the biosynthesis of the capsular polysaccharide. PLoS One (2012) 0.88
Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4. J Biol Chem (2011) 0.88
A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity. J Am Chem Soc (2011) 0.88
Closed femoral nailing in lateral decubitus position without a fracture table: a preliminary report of fifteen patients. Chang Gung Med J (2005) 0.87
Enhancement of rotator cuff tendon-bone healing with injectable periosteum progenitor cells-BMP-2 hydrogel in vivo. Knee Surg Sports Traumatol Arthrosc (2011) 0.87
Assessing computational amino acid beta-turn propensities with a phage-displayed combinatorial library and directed evolution. Structure (2006) 0.85
Factor Xa active site substrate specificity with substrate phage display and computational molecular modeling. J Biol Chem (2008) 0.84
Probiotic Bio-Three induces Th1 and anti-inflammatory effects in PBMC and dendritic cells. World J Gastroenterol (2010) 0.83
Arthroscopic single-bundle anterior cruciate ligament reconstruction with periosteum-enveloping hamstring tendon graft: clinical outcome at 2 to 7 years. Arthroscopy (2010) 0.83
Protein-protein interaction site predictions with three-dimensional probability distributions of interacting atoms on protein surfaces. PLoS One (2012) 0.82
Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. Bioorg Med Chem (2008) 0.81
Prediction of carbohydrate binding sites on protein surfaces with 3-dimensional probability density distributions of interacting atoms. PLoS One (2012) 0.80
Generation and characterization of anti-alpha-enolase single-chain antibodies in chicken. Vet Immunol Immunopathol (2010) 0.80
Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. Chembiochem (2007) 0.80
Classification and analysis of pathology of the long head of the biceps tendon in complete rotator cuff tears. Chang Gung Med J (2012) 0.79
Identification of a new peptide for fibrosarcoma tumor targeting and imaging in vivo. J Biomed Biotechnol (2010) 0.78
Treatment of volar Barton's fractures: comparison between two common surgical techniques. Chang Gung Med J (2006) 0.77
Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders. Structure (2009) 0.77
Signal sequence as a determinant in expressing disulfide-stabilized single chain antibody variable fragments (sc-dsFv) against human VEGF. Mol Biosyst (2010) 0.77
Nitrate-to-nitrite-to-nitric oxide conversion modulated by nitrate-containing {Fe(NO)2}9 dinitrosyl iron complex (DNIC). Inorg Chem (2012) 0.77
The first pharmacophore model for potent NF-kappaB inhibitors. Bioorg Med Chem Lett (2009) 0.77
Distinct interactions of αA-crystallin with homologous substrate proteins, δ-crystallin and argininosuccinate lyase, under thermal stress. Biochimie (2010) 0.77
Kinetic refolding barrier of guanidinium chloride denatured goose delta-crystallin leads to regular aggregate formation. Biophys J (2007) 0.76
Serendipitous discovery of short peptides from natural products as tyrosinase inhibitors. J Chem Inf Model (2014) 0.76
Effect of hyperbaric oxygenation on intervertebral disc degeneration: an in vivo study with sprague-dawley rats. Spine (Phila Pa 1976) (2013) 0.75
Effects of signal sequence on phage-displayed disulfide-stabilized single chain antibody variable fragment (sc-dsFv) libraries. Biochem Biophys Res Commun (2011) 0.75
A New Era for Cancer Target Therapies: Applying Systems Biology and Computer-Aided Drug Design to Cancer Therapies. Curr Pharm Biotechnol (2016) 0.75
Design of phage-displayed cystine-stabilized mini-protein libraries for proteinaceous binder engineering. Methods Mol Biol (2014) 0.75
Substrate phage display for protease substrate sequence characterization: bovine factor Xa as a model system. Methods Mol Biol (2014) 0.75